| Outcome | Apixaban (n = 93) |
Warfarin (n = 335) |
P value |
|---|---|---|---|
| Recurrent VTE, n (%) | 3 (3.2) | 33 (9.9) | .06 |
| Major bleeding, n (%) | 4 (4.3) | 10 (3.0) | .52 |
| CRNM bleeding, n (%) | 1 (1.1) | 9 (2.7) | .70 |
| All-cause mortality, n (%) | 4 (4.3) | 8 (2.4) | .30 |
Please use landscape view or desktop screen to view the content.
Outcomes of Subgroup of Patients with BMI >50 kg/m2 or Weight >140 kg1
Crouch 2022
